Chemokines in progression, chemoresistance, diagnosis, and prognosis of colorectal cancer
Open Access
- 22 July 2022
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 13, 724139
Abstract
Plenty of factors affect the oncogenesis and progression of colorectal cancer in the tumor microenvironment, including various immune cells, stromal cells, cytokines, and other factors. Chemokine is a member of the cytokine superfamily. It is an indispensable component in the tumor microenvironment. Chemokines play an antitumor or pro-tumor role by recruitment or polarization of recruiting immune cells. Meanwhile, chemokines, as signal molecules, participate in the formation of a cross talk among signaling pathways and non-coding RNAs, which may be involved in promoting tumor progression. In addition, they also function in immune escape. Chemokines are related to drug resistance of tumor cells and may even provide reference for the diagnosis, therapy, and prognosis of patients with colorectal cancer.Keywords
This publication has 165 references indexed in Scilit:
- Linking inflammation to tumorigenesis in a mouse model of high-fat-diet-enhanced colon cancerCytokine, 2013
- From sentinel cells to inflammatory culprits: cancer‐associated fibroblasts in tumour‐related inflammationThe Journal of Pathology, 2012
- Macrophage plasticity and polarization: in vivo veritasJournal of Clinical Investigation, 2012
- CXCR2 and CXCR4 antagonistically regulate neutrophil trafficking from murine bone marrowJournal of Clinical Investigation, 2010
- Associations between Smoking, Alcohol Consumption, and Colorectal Cancer, Overall and by Tumor Microsatellite Instability StatusCancer Epidemiology, Biomarkers & Prevention, 2009
- Mesenchymal Stem Cell Transition to Tumor-Associated Fibroblasts Contributes to Fibrovascular Network Expansion and Tumor ProgressionPLOS ONE, 2009
- Cigarettes and alcohol in relation to colorectal cancer: the Singapore Chinese Health StudyBritish Journal of Cancer, 2007
- Cancer and the chemokine networkNature Reviews Cancer, 2004
- Topical chemotherapy with 5-fluorouracilJournal of the American Academy of Dermatology, 1981
- Fluorinated Pyrimidines, A New Class of Tumour-Inhibitory CompoundsNature, 1957